comparemela.com

Latest Breaking News On - Tri specific killer engager - Page 1 : comparemela.com

Why Is GT Biopharma Stock Surging 125?

Shares of GT Biopharma, Inc. (GTBP) are surging over 125% on Monday morning despite no stock-related news statement from the company. GRBP is currently trading at $7.

Nasdaq
Gt-biopharma-inc
Tri-specific-killer-engager

Short Interest in GT Biopharma, Inc. (NASDAQ:GTBP) Decreases By 98.6%

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 800 shares, a decrease of 98.6% from the January 15th total of 58,800 shares. Based on an average daily volume of 5,800 shares, the short-interest ratio […]

Wells-fargo-company
Renaissance-technologies
Nasdaq
Gt-biopharma-company-profile
Gt-biopharma-inc
Atria-wealth-solutions-inc
Get-free-report
Stock-down
Wealth-solutions
Street-group
Tri-specific-killer-engager

GT Biopharma (NASDAQ:GTBP) & PaxMedica (NASDAQ:PXMD) Head to Head Analysis

GT Biopharma (NASDAQ:GTBP) & PaxMedica (NASDAQ:PXMD) Head to Head Analysis
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tarrytown
New-york
United-states
California
Brisbane
Queensland
Australia
Paxmedica-inc
International-inc
Gt-biopharma-inc
Purinix-pharmaceuticals

GT Biopharma, Inc. (NASDAQ:GTBP) Sees Large Increase in Short Interest

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 66,800 shares, an increase of 14.8% from the November 30th total of 58,200 shares. Based on an average trading volume of 118,800 shares, the days-to-cover ratio is currently 0.6 […]

Renaissance-technologies
Atria-wealth-solutions-inc
Wells-fargo-company
Gt-biopharma-inc
Gt-biopharma-company-profile
Nasdaq
Get-free-report
Wealth-solutions
Street-group
Tri-specific-killer-engager
Gt-biopharma

GT Biopharma, Inc. (NASDAQ:GTBP) Short Interest Down 16.8% in October

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 132,900 shares, a decline of 16.8% from the October 15th total of 159,800 shares. Based on an average daily volume of 147,900 shares, […]

Atria-wealth-solutions-inc
Millennium-management
Gt-biopharma-inc
Nasdaq
Get-free-report
Wealth-solutions
Street-corp
Jane-street-group
Tri-specific-killer-engager
Gt-biopharma
Nasdaq-gtbp

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.